ACA
Avoro Capital Advisors Portfolio holdings
AUM
$10.2B
1-Year Est. Return
149.19%
This Fund
S&P 500
1 Year Est. Return
+149.19%
AUM
$10.2B
AUM Growth
-$22.3M
(-0.22%)
Holding
36
Top Buys
| 1 | +$212M | |
| 2 | +$97.2M | |
| 3 | +$55.2M | |
| 4 |
Celcuity
CELC
|
+$28.8M |
| 5 |
Avalo Therapeutics
AVTX
|
+$22M |
Top Sells
| 1 | +$393M | |
| 2 | +$256M | |
| 3 | +$79.9M | |
| 4 |
PTC Therapeutics
PTCT
|
+$52M |
| 5 |
ORKA
Oruka Therapeutics
ORKA
|
+$40.4M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
GH Research
GHRS
$1.65B
| $25.3M | 0.25% |
1,800,000
|
|
||
|
27
Avalo Therapeutics
AVTX
$838M
| $21.1M | 0.21% |
+1,410,000
|
|
||
28
Lexeo Therapeutics
LXEO
$404M
| $10.8M | 0.11% |
1,875,000
-1,425,000
|
|
||
|
WHWK
29
Whitehawk Therapeutics
WHWK
$233M
| $9.83M | 0.1% |
2,849,402
|
|
||
30
MannKind Corp
MNKD
$1.16B
| $5.39M | 0.05% |
2,200,000
-2,244,444
|
|
||
|
31
PTC Therapeutics
PTCT
$6.13B
| – | – |
-685,000
|
|
||
32
State Street SPDR S&P Biotech ETF
XBI
$8.54B
| – | – |
-2,100,000
|
|
||
|
ORKA
33
Oruka Therapeutics
ORKA
$3.53B
| – | – |
-1,333,340
|
|
||
34
Apogee Therapeutics
APGE
$6.19B
| – | – |
-500,000
|
|
||
35
Incyte
INCY
$19.3B
| – | – |
-135,000
|
|
||
|
RNAM
36
DELISTED
Avidity Biosciences
RNAM
| – | – |
-5,455,000
|
|